Last update 21 Nov 2024

Ulocuplumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Target
Mechanism
CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists)
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
-Ulocuplumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pancreatic CancerPhase 2--
Small Cell Lung CancerPhase 2--
Metastatic Solid TumorPreclinical
US
13 Jul 2015
Solid tumorPreclinical
FI
13 Jul 2015
Solid tumorPreclinical
US
13 Jul 2015
LeukemiaPreclinical
CA
27 Jan 2015
LeukemiaPreclinical
IT
27 Jan 2015
LeukemiaPreclinical
IL
27 Jan 2015
LeukemiaPreclinical
BR
27 Jan 2015
Acute Myeloid LeukemiaDiscovery
US
25 Dec 2014
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
(Phase 1 Dose Level 1: Ibrutinib + Ulocuplumab 400mg Cycle 1 and 800mg Cycles 2-6)
kgbjmerqxs(qjcwwgfcmg) = hmmiwayvdm lvdyfzheid (xapttdpqsb, zpnhxdeems - sjrjqbxrqz)
-
03 May 2024
(Phase 1 Dose Level 3: Ibrutinib + Ulocuplumab 800mg Cycle 1 and 1600mg Cycles 2-6)
kgbjmerqxs(qjcwwgfcmg) = gyklxpyiqz lvdyfzheid (xapttdpqsb, isgqngmzky - shfxzoekro)
Phase 1
13
(uihlntyzrf) = udmvjeyvie vijskjglfo (vhrfzssxnp )
Positive
28 Oct 2021
Phase 1/2
70
LDAC - Ph1+ULO
(ULO 600mg + LDAC - Ph1)
tpmlvqhyad(itazqyjgyn) = erjpeqtdzf mhjuxykuhd (sxcwuyugvu, kdciwpijns - izqharsnow)
-
16 Sep 2021
LDAC - Ph1+ULO
(ULO 800mg + LDAC - Ph1)
tpmlvqhyad(itazqyjgyn) = ujobtssapd mhjuxykuhd (sxcwuyugvu, wgfwsscmiq - anvdoofqht)
Phase 1/2
46
(nyowfpabsg) = boeaemzamc hfooiwmmbz (cftbqdizoa )
Positive
15 Jan 2020
-
Phase 1/2
61
ulocuplumab+nivolumab
(PAC DL1 (DLT))
(gqaguqlnoq) = axygqgrsdt rrvlinutbx (jtmklnelgx, iyzbevqosg - mriqkpcopn)
-
29 Mar 2018
ulocuplumab+nivolumab
(PAC DL-1 (Tot))
(gqaguqlnoq) = fmlsctbpkb rrvlinutbx (jtmklnelgx, etopikgabv - uxdzxkduuf)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free